Grantopen🌐 United StatesRFA-CA-27-019

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: May 21, 2026
Response deadline: Oct 19, 2027, 12:00 AM UTC (464d)
Type: Grant
Category: 93.399, 93.395, 93.393, 93.394, 93.396
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-CA-27-019

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
United States · May 21, 2026
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
United States · May 21, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Jun 3, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Jun 3, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
United States · Nov 12, 2024
Metastasis Research Network (U54 Clinical Trial Not Allowed)
United States · Jun 4, 2026

Similar past solicitations

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
United States · Dec 31, 2024
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
United States · Dec 1, 2023
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
United States · Dec 31, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.